2 WEEKS OF TREATMENT WITH DEPRENYL (SELEGILINE) DOES NOT PROLONG L-DOPA EFFECT IN PARKINSONIAN-PATIENTS - A DOUBLE-BLIND CROSSOVER PLACEBO-CONTROLLED TRIAL

被引：22

作者：

RASCOL, O

MONTASTRUC, JL

SENARD, JM

DEMONET, JF

SIMONETTA, M

RASCOL, A

机构：

[1] FAC MED TOULOUSE,PHARMACOL MED LAB & CLIN,INSERM,U317,37 ALLEES JULES GUESDE,F-31073 TOULOUSE,FRANCE

[2] CHU TOULOUSE,SERV PHARMACOL MED & CLIN,INSERM,U317,F-31052 TOULOUSE,FRANCE

[3] CHU PURPAN,SERV NEUROL,TOULOUSE,FRANCE

来源：

NEUROLOGY | 1988年 / 38卷 / 09期

关键词：

D O I：

10.1212/WNL.38.9.1387

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1387 / 1391

页数：5

共 30 条

[1]

ARNETT CD, 1986, J NUCL MED L, V7, P982

[2] INCREASED LIFE EXPECTANCY RESULTING FROM ADDITION OF L-DEPRENYL TO MADOPAR TREATMENT IN PARKINSONS-DISEASE - A LONGTERM STUDY [J].

BIRKMAYER, W ;

KNOLL, J ;

RIEDERER, P ;

YOUDIM, MBH ;

HARS, V ;

MARTON, J .

JOURNAL OF NEURAL TRANSMISSION, 1985, 64 (02) :113-127

[3] POTENTIATION OF ANTI AKINETIC EFFECT AFTER L-DOPA TREATMENT BY AN INHIBITOR OF MAO-B, DEPRENIL [J].

BIRKMAYER, W ;

RIEDERER, P ;

YOUDIM, MBH ;

LINAUER, W .

JOURNAL OF NEURAL TRANSMISSION, 1975, 36 (3-4) :303-326

[4] (-)DEPRENYL IN THE TREATMENT OF PARKINSONS-DISEASE [J].

BIRKMAYER, W ;

RIEDERER, P ;

YOUDIM, MBH .

CLINICAL NEUROPHARMACOLOGY, 1982, 5 (02) :195-230

[5]

BIRKMAYER W, 1977, LANCET, V1, P439

[6]

BRODERSEN P, 1985, ACTA NEUROL SCAND, V71, P494

[7] EXPERIENCES WITH L-DEPRENYL IN PARKINSONISM [J].

CSANDA, E ;

ANTAL, J ;

ANTONY, M ;

CSANAKY, A .

JOURNAL OF NEURAL TRANSMISSION, 1978, 43 (3-4) :263-269

[8]

Csanda E, 1983, J Neural Transm Suppl, V19, P283

[9] DEPRENYL IN PARKINSON DISEASE [J].

EISLER, T ;

TERAVAINEN, H ;

NELSON, R ;

KREBS, H ;

WEISE, V ;

LAKE, CR ;

EBERT, MH ;

WHETZEL, N ;

MURPHY, DL ;

KOPIN, IJ ;

CALNE, DB .

NEUROLOGY, 1981, 31 (01) :19-23

[10]

ESTEGUY M, 1985, REV NEUROL, V141, P413

← 1 2 3 →